RecruitingNCT05459948

The Medacta GMK SpheriKA Post-Marketing Surveillance Study

Medacta GMK® SpheriKA and Kinematic Alignment Technique Multicenter, Post-Market Outcome Study

Sponsor

Medacta International SA

Enrollment

281 participants

Start Date

Jul 30, 2022

Study Type

OBSERVATIONAL

Conditions

knee replacement Arthropathy

Summary

This is a Post-Marketing Surveillance of GMK SpheriKA knee stem prosthesis.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called GMK SpheriKA for people with arthropathy and knee replacement. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.